Beta-adrenergic receptor blocking drugs in psychiatry.
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000437:Alcoholism / Q000188:drug therapy; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000506:poisoning; D000818:Animals; D000928:Antidepressive Agents / Q000037:antagonists & inhibitors; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D000431:Ethanol / Q000037:antagonists & inhibitors; D006556:Heroin Dependence / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D051379:Mice; D011041:Poisoning / Q000188:drug therapy; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D051381:Rats; D013405:Suicide; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000928:Antidepressive Agents; D000431:Ethanol; D011433:Propranolol; D000661:Amphetamine